Click Below to Return to Drug Transparency Home Page:

 

LC-DT Home
 

 

Manufacturer Drug Transparency Guidelines, Reporting Information and Templates


Contact Us

For all report submissions or technical assistance, please use the following email:

Reporting Timeline

Reporting Instructions & Template ~ Pharmaceutical Sales Representatives Registry

NRS 439B.660 – Manufacturer required to provide a complete list of its pharmaceutical sales representatives January 15th annually. A person who is not included on a current list submitted pursuant to subsection 1 shall not market prescription drugs on behalf of a manufacturer.

Reporting Instructions & Template ~ Essential Diabetes Drugs Manufacturer Report

NRS 439B.635 – Manufacturer of certain essential diabetes drugs to prepare and submit report April 1st annually.

Reporting Instructions & Templates ~ Essential Diabetes Drugs Price Increase Report

NRS 439B.640 – Manufacturer of essential diabetes drugs that has undergone significant price increase to summit report April 1st annually.

Resources & Information